A detailed history of Prudential Financial Inc transactions in Biodesix Inc stock. As of the latest transaction made, Prudential Financial Inc holds 29,800 shares of BDSX stock, worth $41,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,800
Previous 29,800 -0.0%
Holding current value
$41,124
Previous $45,000 17.78%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.21 - $1.71 $36,058 - $50,958
29,800 New
29,800 $45,000
Q3 2023

Nov 13, 2023

BUY
$1.04 - $1.74 $25,792 - $43,152
24,800 New
24,800 $40,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.